<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04995276</url>
  </required_header>
  <id_info>
    <org_study_id>8259</org_study_id>
    <nct_id>NCT04995276</nct_id>
  </id_info>
  <brief_title>PostmenopausAL heaLth And DIseAse (PALLADIA) Study</brief_title>
  <acronym>PALLADIA</acronym>
  <official_title>PostmenopausAL heaLth And DIseAse (PALLADIA) Study: Prospective Study of the Incidence and Risk Factors of Chronic Diseases Associated With Menopause</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National and Kapodistrian University of Athens</source>
  <oversight_info>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study of the incidence and risk factors of chronic diseases that are&#xD;
      associated with menopause.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>up to 2025</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronary heart disease</measure>
    <time_frame>up to 2025</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke</measure>
    <time_frame>up to 2025</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes mellitus</measure>
    <time_frame>up to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osteoporotic fractures</measure>
    <time_frame>up to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast cancer</measure>
    <time_frame>up to 2025</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any cancer</measure>
    <time_frame>up to 2025</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Menopause</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study will include 4.000 postmenopausal women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Postmenopausal women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Men Women of reproductive age&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>postmenopausal women</gender_description>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Irene Lambrinoudaki, Prof.</last_name>
    <phone>6977005321</phone>
    <phone_ext>+30</phone_ext>
    <email>ilambrinoudaki@med.uoa.gr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Menopause Clinic, Aretaieio Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attica</state>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Lambrinoudaki, Prof</last_name>
      <phone>6977005321</phone>
      <phone_ext>+30</phone_ext>
      <email>ilambrinoudaki@med.uoa.gr</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2021</study_first_posted>
  <last_update_submitted>July 31, 2021</last_update_submitted>
  <last_update_submitted_qc>July 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National and Kapodistrian University of Athens</investigator_affiliation>
    <investigator_full_name>Irene Lambrinoudaki</investigator_full_name>
    <investigator_title>Professor of Endocrinology</investigator_title>
  </responsible_party>
  <keyword>menopause</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

